Policy recommendations on uptake of biosimilar medicines in the retail market

Positioning Statements on Physician-led Switching for Biosimilar Medicines

Eco-Pharmaco-Stewardship (EPS) initiative – Care for People and Our Environment

Open Public Consultation on the revision of EU rules on medicines for children and rare diseases

Factsheet: Removing barriers to equitable access for timely competition

Factsheet: Market and regulatory reforms to ensure availability and resilience of the supply chain

Factsheet: Evaluating the impact of international trade on access to medicines

Factsheet: Boosting affordable innovations

The Issue of Abuses of Divisional Patent Application

VAM Hurdles